CureWorks focuses on expanding immunotherapy trials and patient access around the world, as well as sharing data and collective expertise to advance novel cell therapies. Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
Seattle Children's has opened a pioneering chimeric antigen receptor T-cell immunotherapy trial for children and young adults with relapsed or refractory HER2-positive central nervous system tumors. Read More
Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that the firm will open an office in London. Read More
Orphan drugs are forecast to remain one of the fastest growth areas of the global pharmaceutical market according to Evaluate’s annual industry report. Read More
Neuroinflammation’s role in neurological diseases Read More
NewLink Genetics Corporation (NASDAQ:NLNK) announced that data from two Phase 2 studies of indoximod, used in combination with other agents, were presented at ASCO 2018 Read More
BioIVT will be hosting a webinar entitled “Whole-cell In Vitro Models Can Predict Clinically-relevant Herb-Drug Interactions (HDIs)” at 11 am ET on June 20. Read More